Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- ritlecitinib
- Ubrelvy (ubrogepant)
Interactions between your drugs
ubrogepant ritlecitinib
Applies to: Ubrelvy (ubrogepant), ritlecitinib
Ritlecitinib can increase the blood levels of ubrogepant. This may increase side effects such as nausea and sleepiness. The usual recommended dose for migraine is 50 mg in individuals who are receiving treatment with ritlecitinib. A second dose, if needed, should not be taken for at least 24 hours after the initial dose. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a different dose to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
ubrogepant food
Applies to: Ubrelvy (ubrogepant)
Grapefruit and grapefruit juice can increase the blood levels of ubrogepant. This may increase side effects such as nausea and sleepiness. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe an alternative that does not interact, or you may need a different dose to safely use your medication with grapefruit and grapefruit juice. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Report options
- Switch to professional interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Kenalog-40
Kenalog-40 is a long-acting corticosteroid injection for intramuscular (into the muscle) or ...
Olumiant
Olumiant is used to treat rheumatoid arthritis, alopecia areata (hair loss), and COVID-19. Includes ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Zilretta
Zilretta (triamcinolone injection) is used for the management of osteoarthritis pain of the knee ...
Rogaine
Rogaine (minoxidil) is used to help regrow new, thicker hair and prevent future hair loss in men ...
Litfulo
Litfulo is used to treat severe alopecia areata in adults and adolescents 12 years and older to ...
Leqselvi
Leqselvi (deuruxolitinib) is a JAK inhibitor used for the treatment of severe hair loss (alopecia ...
Azmacort
Azmacort (triamcinolone) is used to prevent asthma attacks. Includes Azmacort side effects ...
Hair Regrowth Treatment for Women
Hair Regrowth Treatment for Women is used for alopecia
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.